Pharma firm Cipla today said its net profit for the fourth quarter ended March 31 had increased 40.94 per cent to Rs 252.92 crore. The company had a net profit of Rs 179.45 crore in the same quarter ended March 31, 2008, Cipla said in a filing to the Bombay Stock Exchange (BSE).
Total operating income of the company rose to Rs 1,366.74 crore during the quarter under review, as against Rs 1,122.10 crore in the same quarter of the previous fiscal. For the year ended March 31, the company posted a net profit of Rs 767.83 crore, up 9.46 per cent from Rs 701.43 crore in the same period of the previous fiscal.
Material cost (as a percentage of income from operations) decreased during the quarter, mainly on account of sales expenditure, foreign exchange loss (Rs 10 crore loss compared witah Rs 25 crore gain in corresponding quarter of last year) and year-end provisions, the filing added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app